UAB - Center for Clinical and Translational Science

Arm Groups

Study Contact

Detailed Description

Overview: The US military relies on physical training to increase and maintain force readiness. In this study, we hypothesize that epigenetic modification is a primary mechanism by which specific physical exercise training prescriptions transduce warfighter genotype into warfighting phenotype. Our aim with this program is 3- fold. We will (1) identify training methodologies that modify epigenetic responses; (2) characterize epigenetic regulation of physiological processes, pathways and mechanisms associated with moderate and high-intensity physical training, and (3) produce real-time biomarkers of cardiorespiratory and neuromuscular performance that predict physical training outcomes. We will satisfy these goals through the following six research projects: I. Phenotyping the Exercise Dose-Response 1. Determine the effect of exercise Intensity on neuromuscular and cardiorespiratory performance 2. Assess the impact of baseline, pre-training phenotype on acute responsiveness and adaptability to different intensity exercise regimens 3. Determine the effect of exercise intensity on mechanisms regulating muscle protein metabolism, myofiber hypertrophy, and muscle oxidative capacity II. Real-time Genetic and Epigenetic Biomarkers of Performance 1. Identify muscle miRNA that are differentially expressed in response to varying exercise intensities 2. Identify circulating muscle-derived miRNA that are differentially expressed in response to varying exercise intensities 3. Genotype individual athletic potential for biomarker optimization IV. Epigenomic Signatures of Human Performance 1. Identify and correlate exercise induced methylation changes in blood and muscle 2. Functionally link changes in gene expression signatures and physiologic outcomes 3. Define nuclear receptor induced epigenetic signatures in metabolically active tissues V. Exercise Induced Histone Modifications and Chromatin Remodeling 1. Profile histone modification and histone subunit usage signatures 2. Assess chromatin as a signal integration platform for long-term stability VI. Integrative Epigenomics 1. Categorize baseline performance and group subjects 2. Characterize epigenetic changes in response to varied exercise intensities 3. Develop forecasting models from miRNA biomarkers of performance 4. Develop epigenetic regulatory network models using Deep Belief Networks UAB will enroll healthy, untrained men and women who resemble the US soldier. They participate in an exercise dose response training trial that lasts approximately 12 weeks. There are 2 randomly assigned exercise prescriptions: MOD - 3 days per week on treadmill or stationery cycle ergometer, combined with 2 days per week of resistance training; HI - 3 days per week high intensity interval training similar to military high intensity tactical training, combined with high intensity resistance training 2 days per week. Physical performance is evaluated pre-training, mid-training and post-training. Additionally, body composition is evaluated pre-training and post-training. Muscle biopsies and blood draws are performed at pre-training and post-training acute exercise response bouts, and samples are sent to additional study sites for specific evaluations. Recruitment: Participants are recruited through IRB approved advertisements. Informed Consent: Once an individual is identified; meets the inclusion/exclusion criteria (pre-screen); and expresses interest in the study, a member of the research team provides the individual with a consent form to review. A member of the team follows up with the individual to further explain the study and provide an opportunity for the prospective participant to ask any questions. If the person decides to participate, he/she is scheduled for the initial visit. He/she is encouraged to ask any further questions prior to giving written informed consent. Participant Procedures: MOD exercise regimen - 3 days per week of endurance exercise at 70% heart rate reserve for 30 mins on a stationary cycle or treadmill, combined with resistance exercise on 2 of the 3 days. The resistance training prescription involves 3 sets x 10-14 repetitions for each movement, with 1 minute rest between set. The movements include leg press or squat, knee extension, chest press, overhead press, seated row, wide grip pull down, ab crunch, heel raise, triceps push down, bicep curls. Resistance loads are progressed when 14 repetitions are achieved for 2 of 3 sets. Heart rate is monitored throughout each session. HI Exercise regimen - 3 days per week of maximum intensity interval exercise, combined with resistance exercise on 2 of the 3 days. Instead of moderate intensity endurance exercise, participants in this group perform 10 high-intensity intervals (30 sec of work, 30 sec of rest) including box jumps, burpees, split squat jumps, kettle bell swings, cycling sprints, battle ropes, wall ball, dips, etc. The resistance training prescription involves 3 sets x 8-10 repetitions for the same movements as MOD, but with supersets of two movements. Resistance loads are progressed when 10 repetitions are achieved for 2 of 3 sets. Rest periods are 30-45 seconds between supersets. Heart rate is monitored throughout each session. DXA Scan -The dual energy x-ray absorptiometry (DXA) procedure for determination of body composition (muscle, fat, bone) involves minor x-ray exposure. DXA will be performed at weeks 0, and 12. The effective dose exposure is comparable to 4 hours of sun exposure Urine Pregnancy Test - All females who have had at least one menstrual cycle have a urine pregnancy test at initial assessment and prior to each DEXA scan. All females who have had at least one menstrual cycle are asked questions pertaining to their menstrual cycle. Because hormone levels may have significant impact on biospecimen analysis, the acute exercise bout with muscle and blood collections after the intervention period will be timed to occur in the same phase of the menstrual cycle as the pre-training acute response exercise bout. Muscle Sampling - A total of 7 muscle samples are collected by percutaneous needle muscle biopsy from the vastus lateralis using established procedures: 3 collected before and after the first acute response exercise bout in the pre-training state (pre-exercise, 3 h post-exercise, 24 h post-exercise); 3 collected before and after the acute response exercise bout in the post-training state (pre-exercise, 3 h post-exercise, 24 h post-exercise); 1 collected at a follow up visit 4 weeks after the conclusion of the intervention period. Blood Sampling - A total of 9 blood samples are collected by venipuncture using established procedures: 4 collected before and after the first acute response exercise bout in the pre-training state (pre-exercise, 15 min post-exercise, 3 h post-exercise, 24 h post-exercise); 3 collected before and after the acute response exercise bout in the post-training state (pre-exercise, 15 min post-exercise, 3 h post-exercise, 24 h post-exercise); 1 collected at a follow up visit 4 weeks after the conclusion of the intervention period. Exercise Performance Evaluations - 1-repetition maximum (1RM) strength on upper and lower body movements, peak aerobic capacity (VO2peak) on a cycle ergometer, Wingate anaerobic power test, peak muscle power of the knee extensors using a computer-controlled dynamometer, and vertical jump test are conducted before and after the intervention period. Some performance tests are also conducted mid-intervention (approximately week 6). Dietary Intake - Dietary intake will be monitored using a validated 24 hour recall at weeks 0 and 12. Quality Assurance: Exercise Sessions: Subjects will be carefully instructed in proper methods and are monitored continuously. All exercise sessions are performed under full supervision by experienced, certified staff [Certified Strength and Conditioning Specialist (National Strength and Conditioning Association) and/or Certified Exercise Specialist (American College of Sports Medicine)]. Biospecimens Collection: All muscle biopsies and blood draws are performed by trained, professional clinician's and research staff who are experienced and locally certified. DXA scans: All DXA scans are performed by trained technicians at UAB. Genetic Testing: Genetic testing of samples will be linked to a unique participant ID that will not identify a participant in any way. Linkages to personal health information are kept secure at the clinical site (UAB). The research will be conducted by well trained and experienced personnel who will be identified to the IRB prior to working on this study. PI will be ultimately responsible for data and safety monitoring: (i) Keeping all study documents updated and available for inspection by the sponsor, UAB IRB, and other authorized reviewers; (ii) Ensuring that appropriate mechanisms to protect the safety of study participants are being followed; (iii) Ensuring adherence to protocol requirements; and (iv) Ensuring that data are accurate, complete, and secure. All documents pertaining to the conduct of the study will be kept on file by the PIs. Even though this trial does not meet the requirements for a Data and Safety Monitoring Board, we will follow a proactive, Data and Safety Monitoring Plan as described below. 1. Weekly reviews at investigators/staff team meetings of recruitment progress notes, updates/reports from the exercise facility, laboratories, and data management staff, and newly available data. 2. PIs' quarterly review of safety and interim data analysis. 3. Annual review performed by the UAB IRB. 4. Semi-annual patient safety review by the study team. All non-serious AEs will be documented, and a summary delivered to the UAB IRB at pre-determined intervals (at least annually). Any SAEs will be reported to the UAB IRB within 3 days of their discovery. Aggregate reports of AEs/SAEs will be delivered to the sponsor as mandated. If an AE (serious or non-serious) occurs, the PI will be immediately notified. Depending on the event, follow up may require additional tests or medical procedures as indicated, and/or referral to a specialist. The study physicians will make such decisions. Depending on the type of AE/SAE, the PIs may opt to discontinue the subject from the study. The PIs will be ultimately responsible for evaluating each AE for relationship to the protocol, seriousness and expectedness, any impact on the risk-to-benefit ratio, and whether modifications are needed to the informed consent document and/or protocol. The PIs will also have the responsibility of determining whether the protocol must be suspended until satisfactory modifications are made; however, ultimate authority in such cases will rest with the UAB IRB.